Small intestine bacterial overgrowth and environmental enteropathy in Bangladeshi children

mBio

Volumn 7, Issue 1, 2016, Pages

  Donowitz, Jeffrey R ^a   Haque, Rashidul ^b   Kirkpatrick, Beth D ^c   Alam, Masud ^b   Lu, Miao ^d   Kabir, Mamun ^b   Kakon, Shahria Hafiz ^b   Islam, Bushra Zarin ^b   Afreen, Sajia ^b   Musa, Abu ^b   Khan, Shaila Sharmeen ^b   Colgate, E Ross ^c   Carmolli, Marya P ^c   Ma, Jennie Z ^d   Petri, William A ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; LITHOSTATHINE; REG1B PROTEIN, HUMAN;

ADULT; ARTICLE; BACTERIAL OVERGROWTH; BANGLADESHI; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIARRHEA; DISEASE ASSOCIATION; ENTERITIS; ENTEROPATHY; ENVIRONMENTAL ENTEROPATHY; FECES ANALYSIS; FEMALE; HUMAN; HYDROGEN BREATH TEST; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEIGHBORHOOD; PRIORITY JOURNAL; SANITATION; SMALL INTESTINE BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; BANGLADESH; BLIND LOOP SYNDROME; CHEMISTRY; COMPLICATION; ENVIRONMENTAL EXPOSURE; FECES; PATHOLOGY; POVERTY; PREVALENCE; RISK FACTOR; SMALL INTESTINE;

BANGLADESH; BLIND LOOP SYNDROME; CHILD; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FECES; HUMANS; INTESTINE, SMALL; LEUKOCYTE L1 ANTIGEN COMPLEX; LITHOSTATHINE; MALNUTRITION; POVERTY; PREVALENCE; RISK FACTORS;

EID: 84960158137     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02102-15     Document Type: Article

References (53)

1. O’Mahony S, Shanahan F. 2010. Enteric microbiota and small intestinal bacterial overgrowth, p 1769. In Feldman M, Friedman L, Brandt L (ed), Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management, 9th ed. Saunders, Philadelphia, PA.
2. Tabaqchali S, Hatzioannou J, Booth CC. 1968. Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet 292:12–16. http://dx.doi.org/10.1016/S0140-6736(68)92888-2.
3. Rosenberg IH, Hardison WG, Bull DM. 1967. Abnormal bile-salt patterns and intestinal bacterial overgrowth associated with malabsorption. N Engl J Med 276:1391–1397. http://dx.doi.org/10.1056/NEJM196706222762501.
4. Lee WB, Hamilton SM, Harris JP, Schwab IR. 2005. Ocular complications of hypovitaminosis A after bariatric surgery. Ophthalmology 112: 1031–1034. http://dx.doi.org/10.1016/j.ophtha.2004.12.045.
5. Di Stefano M, Veneto G, Malservisi S, Corazza GR. 2001. Small intestine bacterial overgrowth and metabolic bone disease. Dig Dis Sci 46: 1077–1082. http://dx.doi.org/10.1023/A:1010722314493.
6. Schjønsby H. 1977. Osteomalacia in the stagnant loop syndrome. Acta Med Scand 603:39–41.
7. Brin MF, Fetell MR, Green PH, Kayden HJ, Hays AP, Behrens MM, Baker H. 1985. Blind loop syndrome, vitamin E malabsorption, and spinocerebellar degeneration. Neurology 35:338–342. http://dx.doi.org/10.1212/WNL.35.3.338.
8. Ramotar K, Conly JM, Chubb H, Louie TJ. 1984. Production of menaquinones by intestinal anaerobes. J Infect Dis 150:213–218. http://dx.doi.org/10.1093/infdis/150.2.213.
9. Conly JM, Stein K. 1992. The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis. Prog Food Nutr Sci 16:307–343.
10. Jonas A, Flanagan PR, Forstner GG. 1977. Pathogenesis of mucosal injury in the blind loop syndrome. Brush border enzyme activity and glycoprotein degradation. J Clin Invest 60:1321–1330. http://dx.doi.org/10.1172/JCI108891.
11. Giannella RA, Rout WR, Toskes PP. 1974. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology 67:965–974.
12. Toskes PP, Giannella RA, Jervis HR, Rout WR, Takeuchi A. 1975. Small intestinal mucosal injury in the experimental blind loop syndrome. Gastroenterology 68:1193–1203.
13. Riepe SP, Goldstein J, Alpers DH. 1980. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J Clin Invest 66: 314–322. http://dx.doi.org/10.1172/JCI109859.
14. Maxwell JD, Ang L, Cleeve HJ, McGouran RC. 1982. Intestinal bypass in the rat: a model for growth failure, liver disease, and jejunal bacterial overgrowth in marasmus and kwashiorkor. J Pediatr Gastroenterol Nutr 1:417–426. http://dx.doi.org/10.1097/00005176-198201030-00024.
15. Jones EA, Craigie A, Tavill AS, Franglen G, Rosenoer VM. 1968. Protein metabolism in the intestinal stagnant loop syndrome. Gut 9:466–469. http://dx.doi.org/10.1136/gut.9.4.466.
16. Rutgeerts L, Mainguet P, Tytgat G, Eggermont E. 1974. Enterokinase in contaminated small-bowel syndrome. Digestion 10:249–254. http://dx.doi.org/10.1159/000197543.
17. King CE, Toskes PP. 1981. Protein-losing enteropathy in the human and experimental rat blind-loop syndrome. Gastroenterology 80:504–509.
18. Parlesak A, Klein B, Schecher K, Bode JC, Bode C. 2003. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc 51:768–773. http://dx.doi.org/10.1046/j.1365-2389.2003.51259.x.
19. Brandt LJ, Bernstein LH, Wagle A. 1977. Production of vitamin B12 analogues in patients with small-bowel bacterial overgrowth. Ann Intern Med 87:546–551.
20. Welkos SL, Toskes PP, Baer H. 1981. Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology 80:313–320.
21. Giannella R, Broitman S, Zamcheck N. 1972. Competition between bacteria and intrinsic factor for vitamin B 12: implications for vitamin B 12 malabsorption in intestinal bacterial overgrowth. Gastroenterology 62: 255–260.
22. Lakhani SV, Shah HN, Alexander K, Finelli FC, Kirkpatrick JR, Koch TR. 2008. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res 28: 293–298. http://dx.doi.org/10.1016/j.nutres.2008.03.002.
23. Tabaqchali S, Pallis C. 1970. Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis. Gut 11:1024–1028. http://dx.doi.org/10.1136/gut.11.12.1024.
24. Riordan SM, McIver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. 1997. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol 32:556–563. http://dx.doi.org/10.3109/00365529709025099.
25. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. 2009. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49:1877–1887. http://dx.doi.org/10.1002/hep.22848.
26. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC. 1996. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand J Gastroenterol 31:977–984. http://dx.doi.org/10.3109/00365529609003117.
27. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Thomas MC, Bolin TD. 2001. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol 96: 494–500. http://dx.doi.org/10.1111/j.1572-0241.2001.03533.x.
28. Jones HF, Davidson GP, Brooks DA, Butler RN. 2011. Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms? J Pediatr Gastroenterol Nutr 52:632–634. http://dx.doi.org/10.1097/MPG.0b013e31820d5c16.
29. dos Reis JC, de Morais MB, Oliva CA, Fagundes-Neto U. 2007. Breath hydrogen test in the diagnosis of environmental enteropathy in children living in an urban slum. Dig Dis Sci 52:1253–1258. http://dx.doi.org/10.1007/s10620-006-9288-9.
30. Pereira SP, Khin-Maung U, Bolin TD, Nyunt-Nyunt Wai, Duncombe VM, Myo Khin, Linklater JM. 1991. A pattern of breath hydrogen excretion suggesting small bowel bacterial overgrowth in Burmese village children. J Pediatr Gastroenterol Nutr 13:32–38. http://dx.doi.org/10.1097/00005176-199107000-00006.
31. Mello CS, Tahan S, Melli LC, Rodrigues MS, de Mello RM, Scaletsky IC, de Morais MB. 2012. Methane production and small intestinal bacterial overgrowth in children living in a slum. World J Gastroenterol 18: 5932. http://dx.doi.org/10.3748/wjg.v18.i41.5932.
32. Khin-Maung U, Pereira SP, Bolin TD, Duncombe VM, Myo Khin, Nyunt-Nyunt Wai, Linklater JM. 1990. Malabsorption of carbohydrate from rice and child growth: a longitudinal study with the breath-hydrogen test in Burmese village children. Am J Clin Nutr 52:348–352.
33. Khin-Maung U, Bolin TD, Duncombe VM, Myo Khin, Nyunt-Nyunt Wai, Pereira SP, Linklater JM. 1992. Epidemiology of small bowel bacterial overgrowth and rice carbohydrate malabsorption in Burmese (Myanmar) village children. Am J Trop Med Hyg 47:298–304.
34. Lagos R, Fasano A, Wasserman SS, Prado V, Martin SO, Abrego P, Losonsky GA, Alegria S, Levine MM. 1999. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis 180:1709–1712. http://dx.doi.org/10.1086/315051.
35. Berkman DS, Lescano AG, Gilman RH, Lopez SL, Black MM. 2002. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet 359: 564–571. http://dx.doi.org/10.1016/S0140-6736(02)07744-9.
36. Jiang NM, Tofail F, Moonah SN, Scharf RJ, Taniuchi M, Ma JZ, Hamadani JD, Gurley ES, Houpt ER, Azziz-Baumgartner E, Haque R, Petri WA. 2014. Febrile illness and pro-inflammatory cytokines are associated with lower neurodevelopmental scores in Bangladeshi infants living in poverty. BMC Pediatr 14:50. http://dx.doi.org/10.1186/1471-2431-14-50.
37. Mendez MA, Adair LS. 1999. Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J Nutr 129:1555–1562.
38. Korpe PS, Petri WA, Jr. 2012. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 18: 328–336. http://dx.doi.org/10.1016/j.molmed.2012.04.007.
39. Bauer TM, Schwacha H, Steinbrückner B, Brinkmann FE, Ditzen AK, Aponte JJ, Pelz K, Berger D, Kist M, Blum HE. 2002. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 97:2364–2370. http://dx.doi.org/10.1111/j.1572-0241.2002.05791.x.
40. Lunn PG, Northrop-Clewes CA, Downes RM. 1991. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 338:907–910. http://dx.doi.org/10.1016/0140-6736(91)91772-M.
41. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F, Scalici C, Montalto G, Di Fede G, Rini G, Notarbartolo A, Averna MR. 2003. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem 49: 861–867. http://dx.doi.org/10.1373/49.6.861.
42. Taniuchi M, Sobuz SU, Begum S, Platts-Mills JA, Liu J, Yang Z, Wang XQ, Petri WA, Jr., Haque R, Houpt ER. 2013. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis 208:1794–1802. http://dx.doi.org/10.1093/infdis/jit507.
43. Donowitz JR, Petri WA. 2015. Pediatric small intestine bacterial overgrowth in low-income countries. Trends Mol Med 21:6–15. http://dx.doi.org/10.1016/j.molmed.2014.11.001.
44. Cullen JJ, Caropreso DK, Ephgrave KS. 1995. Effect of endotoxin on canine gastrointestinal motility and transit. J Surg Res 58:90–95. http://dx.doi.org/10.1006/jsre.1995.1015.
45. Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T. 2001. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 280: G368–G380.
46. Husebye E, Skar V, Høverstad T, Iversen T, Melby K. 1995. Abnormal intestinal motor patterns explain enteric colonization with Gram-negative bacilli in late radiation enteropathy. Gastroenterology 109:1078–1089. http://dx.doi.org/10.1016/0016-5085(95)90565-0.
47. Omoike IU, Abiodun PO. 1989. Upper small intestinal microflora in diarrhea and malnutrition in Nigerian children. J Pediatr Gastroenterol Nutr 9:314–321.
48. Kirkpatrick BD, Colgate ER, Mychaleckyj JC, Haque R, Dickson DM, Carmolli MP, Nayak U, Taniuchi M, Naylor C, Qadri F, Ma JZ, Alam M, Walsh MC, Diehl SA, PROVIDE Study Teams, Petri WA, Jr. 2015. The “Performance of Rotavirus and Oral Polio Vaccines in Developing Countries” (PROVIDE) study: description of methods of an interven- tional study designed to explore complex biologic problems. Am J Trop Med Hyg 92:744–751. http://dx.doi.org/10.4269/ajtmh.14-0518.
49. Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, Parodi A, Usai-Satta P, Vernia P, Anania C, Astegiano M, Barbara G, Benini L, Bonazzi P, Capurso G, Certo M, Colecchia A, Cuoco L, Di Sario A, Festi D, Lauritano C, Miceli E, Nardone G, Perri F, Portincasa P, Risicato R, Sorge M, Tursi A, 1st Rome H2-Breath Testing Consensus Conference Working Group. 2009. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 29:1–49. http://dx.doi.org/10.1111/j.1365-2036.2009.03951.x.
50. Mahmud MA, Spigt M, Bezabih AM, Pavon IL, Dinant GJ, Velasco RB. 2015. Efficacy of handwashing with soap and nail clipping on intestinal parasitic infections in school-aged children: a factorial cluster randomized controlled trial. PLOS Med 12:e1001837. http://dx.doi.org/10.1371/journal.pmed.1001837.
51. Peterson KM, Buss J, Easley R, Yang Z, Korpe PS, Niu F, Ma JZ, Olortegui MP, Haque R, Kosek MN, Petri WA, Jr. 2013. REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am J Clin Nutr 97:1129–1133. http://dx.doi.org/10.3945/ajcn.112.048306.
52. Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y. 2005. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 40:450–455. http://dx.doi.org/10.1097/01.MPG.0000154657.08994.94.
53. Konikoff MR, Denson LA. 2006. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12:524–534. http://dx.doi.org/10.1097/00054725-200606000-00013.